Mercer Global Advisors
NEPH icon

Mercer Global Advisors’s Nephros NEPH Stock Holding History

Mercer Global Advisors’s Portfolio NEPH Stock Details NEPH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$44.6K Buy
+12,500
New +$40.6K ﹤0.01% 4372

Other funds holding NEPH

VCM
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
CC
Cornerstone Capital Palo Alto, California $1.12B AUM 28.84% 1-Year Est. Return
BA
Bard Associates Chicago, Illinois $451M AUM 66.6% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
MFIM
Mesirow Financial Investment Management Chicago, Illinois $6.37B AUM 23.22% 1-Year Est. Return
HighTower Advisors
HighTower Advisors Chicago, Illinois $103B AUM 28.65% 1-Year Est. Return
NA
Navellier & Associates Reno, Nevada $1.26B AUM 95.39% 1-Year Est. Return
VFT
Vanguard Fiduciary Trust Malvern, Pennsylvania $454B AUM

Mercer Global Advisors's NEPH Position: Q2 2026 in Review

Mercer Global Advisors opened a new position in Nephros (NEPH) in Q2 2026: 12,500 shares worth $44.6K. The stake represents ﹤0.01% of the portfolio and ranks #4372 among its holdings.

29 funds tracked by Wall St. Rank hold NEPH as of Q2 2026.

  • Mercer Global Advisors held 12,500 shares of Nephros worth $44.6K as of Q2 2026.
  • Nephros was a new Mercer Global Advisors position in Q2 2026.
  • Nephros made up ﹤0.01% of Mercer Global Advisors's portfolio in Q2 2026, its #4372 holding.
  • 29 funds tracked by Wall St. Rank held Nephros as of Q2 2026.

Based on Mercer Global Advisors's 13F filing for Q2 2026, filed 11 Aug 2026.